Quaker Houghton Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $2B+7.4% YoYTTM through 30 Jun 2026
Net Income $97.7M-16.3% YoYTTM through 30 Jun 2026
Free Cash Flow $74.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 35.9% |
| EBITDA Margin | 11.2% |
| Operating Margin | 2.8% |
| Net Margin | 4.9% |
Returns
7.1%ROE
3.4%ROA
4.7%ROIC
Balance Sheet Health
Debt / Equity0.63x
Current Ratio2.42x
Net Debt$691.4M
Cash & Equivalents$155.1M
Quality Metrics
Altman Z-Score2.54
Piotroski F-Score6 / 9
FCF Margin3.8%
Rule of 406.6
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $1.9B
Diluted EPS$5.58TTMFY2025: $-0.14
Dividend
$1.52Per share, FY20260.96%Yield-1.0%5-yr growth
Capital Allocation
R&D Spend$60.7M
Capex Intensity2.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Americas | $865.3M | View detailsAmericas segment experienced soft underlying end market activity and lower net sales, partially offset by new business wins and acquisitions. | |
| EMEA | View detailsEMEA segment was heavily impacted by soft market conditions, leading to an $88.8 million non-cash goodwill impairment charge in 2025. | ||
| Asia/Pacific | View detailsAsia/Pacific segment continues to show strong positive momentum, delivering consecutive quarters of organic volume growth driven by new business wins. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.